FDA.reportPublic FDA data

NDC 51662-1489-2 - DOPAMINE HYDROCHLORIDE

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
51662-1489
Requested NDC
51662-1489-2
Package NDCs from labels
51662-1489-1, 51662-1489-2, 51662-1489-3
Manufacturer
HF Acquisition Co LLC, DBA HealthFirst
Effective date
2024-02-22
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
DOPAMINE HYDROCHLORIDE - HF Acquisition Co LLC, DBA HealthFirstHF Acquisition Co LLC, DBA HealthFirst2024-02-22HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
51662-1489-1DOPAMINE HYDROCHLORIDE5 mL in 1 VIAL, SINGLE-DOSEINJECTION55
51662-1489-2DOPAMINE HYDROCHLORIDE1 in 1 POUCHINJECTION15
51662-1489-2DOPAMINE HYDROCHLORIDE5 mL in 1 VIAL, SINGLE-DOSEINJECTION55
51662-1489-3DOPAMINE HYDROCHLORIDE25 in 1 CASEINJECTION255

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
51662-1489DOPAMINE HYDROCHLORIDE INJECTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST]5Current NDC, Legacy NDC, 4 package rows20240224_c901b461-4f98-da0a-e053-2a95a90a106e.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 5 of 5 · 81 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DopamineDOPAMINE HYDROCHLORIDEBioActive Nutritional2e456b07-8b7b-463a-8cf5-1d7a51985b062016-08-16WarningsExact identifier
unii: 7L3E358N9L

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.